Impact on Employers of the FDA Approval of the Pfizer-BioNTech COVID-19 Vaccine

Impact on Employers of the FDA Approval of the Pfizer-BioNTech COVID-19 Vaccine Thumbnail

The U.S. Food and Drug Administration (“FDA”) recently approved use of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of the COVID-19 disease in individuals 16 years of age or older. Previously, all COVID-19 vaccinations administered in the United States were approved through Emergency Use Authorization (“EUA”), which enables the FDA to allow for use of…

Read More

POSTED IN: COVID-19, Employment Law, News